Safety and Hospital Costs Averted Using a Rapid Outpatient Management Strategy for Transient Ischemic Attack and Minor Strokes: The RAVEN Clinic.
cerebrovascular disorders
ischemic attack
safety
stroke
techniques
transient
Journal
The Neurohospitalist
ISSN: 1941-8744
Titre abrégé: Neurohospitalist
Pays: United States
ID NLM: 101558199
Informations de publication
Date de publication:
Apr 2021
Apr 2021
Historique:
entrez:
1
4
2021
pubmed:
2
4
2021
medline:
2
4
2021
Statut:
ppublish
Résumé
Patients presenting to emergency departments (ED) with transient ischemic attack and minor strokes (TIAMS) are often admitted for evaluation, though experience in other countries have suggested that an expedited outpatient care models may be a safe alternative. We hypothesized that a rapid access clinic for select TIAMS was feasible and would avert hospitalization costs. This retrospective analysis included patients presenting to our institution's ED with TIAMS and NIHSS ≤5 in calendar year 2017. We referred low-risk patients with TIAMS to a Rapid Access Vascular Evaluation-Neurology (RAVEN) clinic within 24 hours of ED discharge. We identified admitted patients who met RAVEN criteria at ED presentation. Rates of follow-up to the RAVEN clinic were recorded. Financial data collected included total hospital costs and time spent in the ED, as well hospital length of stay for admitted patients with low-risk TIAMS. In 2017, 149 patients were referred to RAVEN clinic and 50 patients were admitted. Of the RAVEN patients 99 (94%) appeared as scheduled. None had clinical changes between ED discharge and clinical evaluation. One patient required hospitalization at the RAVEN evaluation. When compared to RAVEN patients, admitted patients had significantly higher $7,719 (SD 354) total hospital costs and were hospitalized for 2 days on average. Overall, the RAVEN strategy averted approximately $764,000 in hospitalization costs and 208 hospital bed-days in accounting year 2017. For select patients presenting with TIAMS without disabling deficits, a rapid outpatient evaluation may be feasible while averting significant total hospital costs and preserving inpatient hospital beds.
Identifiants
pubmed: 33791052
doi: 10.1177/1941874420972236
pii: 10.1177_1941874420972236
pmc: PMC7958688
doi:
Types de publication
Journal Article
Langues
eng
Pagination
107-113Subventions
Organisme : NHLBI NIH HHS
ID : R01 HL146811
Pays : United States
Organisme : NCATS NIH HHS
ID : KL2 TR001874
Pays : United States
Organisme : NHLBI NIH HHS
ID : R01 HL132347
Pays : United States
Organisme : NHLBI NIH HHS
ID : R01 HL141811
Pays : United States
Organisme : NHLBI NIH HHS
ID : R01 HL146911
Pays : United States
Informations de copyright
© The Author(s) 2020.
Déclaration de conflit d'intérêts
Declaration of Conflicting Interests: The author(s) declared no potential conflicts of interest with respect to the research, authorship, and/or publication of this article.
Références
Int J Stroke. 2016 Oct;11(8):874-881
pubmed: 27312679
Eur J Neurol. 2013 Feb;20(2):338-43
pubmed: 22928874
Neurology. 2016 Apr 26;86(17):1582-9
pubmed: 27016521
J Emerg Med. 2018 May;54(5):636-644
pubmed: 29321107
Ann Emerg Med. 2007 Aug;50(2):109-19
pubmed: 17490788
Stroke. 2016 Feb;47(2):581-641
pubmed: 26696642
Front Neurol Neurosci. 2014;33:30-40
pubmed: 24157555
Am J Med Qual. 2008 Sep-Oct;23(5):336-41
pubmed: 18820138
J Psychosom Res. 2016 Jul;86:60-2
pubmed: 27302548
Crit Care Med. 2009 Nov;37(11):2882-7
pubmed: 19866504
Am J Emerg Med. 2016 Jun;34(6):1163-4
pubmed: 27005416
Stroke. 2013 Sep;44(9):2500-5
pubmed: 23847249
N Engl J Med. 2020 May 14;382(20):1933-1941
pubmed: 32402163
Am J Emerg Med. 2013 Sep;31(9):1349-51
pubmed: 23906624
Lancet. 2007 Oct 20;370(9596):1432-42
pubmed: 17928046
Stroke. 2014 Jul;45(7):2160-236
pubmed: 24788967
Neurology. 2011 Dec 13;77(24):2082-8
pubmed: 22094477
Ann Emerg Med. 2019 Oct;74(4):562-571
pubmed: 31326206